Kakar Puneet, Boos Christopher J, Lip Gregory Y H
Hemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.
Vasc Health Risk Manag. 2007;3(1):109-16.
Atrial fibrillation (AF) is a condition of genuine clinical concern. This arrhythmia increases patient morbidity and mortality, most notably due to stroke, thromboembolism and heart failure. Consequentially, there is a strong impetus to acquire a greater understanding of its natural history and course in order to provide crucial evidence-based treatment and resource allocation in the future. The objective of this review article is to present a concise overview of the management of AF, with reference to the recent evidence-based National Institute of Clinical Excellence (NICE) National Clinical Guidelines for the management of AF.
心房颤动(AF)是一种真正值得临床关注的病症。这种心律失常会增加患者的发病率和死亡率,最显著的是由于中风、血栓栓塞和心力衰竭。因此,迫切需要更深入地了解其自然病史和病程,以便在未来提供关键的循证治疗和资源分配。这篇综述文章的目的是参考最近基于证据的英国国家临床优化研究所(NICE)关于心房颤动管理的国家临床指南,简要概述心房颤动的管理。